Dry Eye Market in UK - 2022 Edition

August 2022 | 77 pages | ID: D740A8053540EN
Gen Consulting Company

Abstracts

According to latest analysis by Gen Consulting Company, the dry eye market in UK is poised to grow by USD 48 million during 2022-2028, progressing at a CAGR of 4.2% during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into dry eye market in UK. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the dry eye industry.

This industry report offers market estimates and forecasts of the UK market, followed by a detailed analysis of the drug form, product, and distribution channel. The UK market for dry eye can be segmented by drug form: eye ointment, gel, liquid drops, others. Dry eye market is further segmented by product: anti-inflammatory drugs, artificial lubricant eye drops, autologous serum eye drops. Based on distribution channel, the dry eye market is segmented into: hospitals, online pharmacies, pharmacies & drug stores, others.

By drug form:

• eye ointment
• gel
• liquid drops
• others

By product:

• anti-inflammatory drugs
• artificial lubricant eye drops
• autologous serum eye drops

By distribution channel:

• hospitals
• online pharmacies
• pharmacies & drug stores
• others

The report explores the recent developments and profiles of key vendors in the Dry Eye Market in UK, including Allergan plc (AbbVie Inc.), Bausch & Lomb Incorporated, I-MED Pharma, Inc., Johnson & Johnson, LGL Ltd., Novartis AG, Otsuka Pharmaceutical Co., Ltd. (OPC), Santen Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., Vision Direct Group Limited, among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the dry eye market in UK.
• To classify and forecast the dry eye market in UK based on drug form, product, distribution channel.
• To identify drivers and challenges for the dry eye market in UK.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the dry eye market in UK.
• To identify and analyze the profile of leading players operating in the dry eye market in UK.

Why Choose This Report

• Gain a reliable outlook of the dry eye market in UK forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY DRUG FORM

Eye ointment
Gel
Liquid drops
Others

PART 6. MARKET BREAKDOWN BY PRODUCT

Anti-inflammatory drugs
Artificial lubricant eye drops
Autologous serum eye drops

PART 7. MARKET BREAKDOWN BY DISTRIBUTION CHANNEL

Hospitals
Online pharmacies
Pharmacies & drug stores
Others

PART 8. KEY COMPANIES

Allergan plc (AbbVie Inc.)
Bausch & Lomb Incorporated
I-MED Pharma, Inc.
Johnson & Johnson
LGL Ltd.
Novartis AG
Otsuka Pharmaceutical Co., Ltd. (OPC)
Santen Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Vision Direct Group Limited
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER